Gangrenous Cholecystitis After a Missed Diagnosis

Acute cholecystitis is inflammation of the gallbladder, most often caused by a gallstone that lodges in the cystic duct and stops bile from draining. Pressure builds, the wall becomes edematous, and the inflammatory cascade begins. When the obstruction clears within hours or the patient reaches the operating room promptly, the gallbladder usually comes out cleanly and the patient recovers without lasting injury. When the obstruction persists and the inflammation is left to escalate, the clinical picture shifts. That is where gangrenous cholecystitis begins.

Gangrenous cholecystitis is the stage at which the gallbladder wall becomes ischemic — the blood supply is compromised by the swelling and the rising intraluminal pressure, and the tissue begins to die. The Tokyo Guidelines TG18, the international diagnostic and severity-grading reference for acute cholecystitis, classifies gangrenous cholecystitis as a Grade III (severe) case with organ dysfunction or with a gallbladder that is gangrenous, perforated, abscessed, or producing biliary peritonitis. Reported mortality in the published cohorts ranges roughly from 15 to 50 percent, depending on age, comorbidity, and how long the patient has been in the progression before a diagnosis is finally made. In older adults, diabetics, and immunocompromised patients, the numbers sit closer to the higher end.

This is not a rare pathology, and it is not a mysterious one. It is the predictable endpoint of an untreated cystic duct obstruction, and the medical literature has described the trajectory for more than a century.

The sequence from onset to catastrophe is compressed. A working familiarity with the timeline is what separates ER physicians who catch cholecystitis at first presentation from those who miss it.

In the first twenty-four hours after the cystic duct obstructs, the gallbladder wall becomes edematous and inflamed. Pain is present, usually in the right upper quadrant, sometimes radiating to the back or right shoulder. Fever may be low-grade. The white blood cell count may be only mildly elevated. This is the window where the diagnosis is easiest to make clinically and where the workup — right-upper-quadrant ultrasound, CBC, liver function tests, lipase — is most productive.

By day two to three, if the obstruction has not been relieved, the wall becomes ischemic. The venous drainage fails first, then the arterial supply. The wall transitions from edematous to frankly necrotic. On imaging, the wall thickening becomes striking, pericholecystic fluid appears, and sometimes a striated or disrupted wall pattern emerges. Clinically the patient looks sicker — higher fever, tachycardia, rigors, rising white blood cell count, abdominal tenderness that now extends beyond the right upper quadrant.

Perforation typically follows the gangrenous stage by another one to three days, sometimes sooner. When the wall perforates, bile and any remaining gallstones spill into the peritoneal cavity. Biliary peritonitis and bacteremia follow quickly, and sepsis becomes the clinical problem that dominates the rest of the admission. A patient who walked into the ER three days earlier with right-upper-quadrant pain and was sent home with a proton pump inhibitor is now in the intensive care unit.

The reason this pathology is missed so often is not a mystery. The Tokyo Guidelines TG18 laid out the diagnostic criteria precisely because this entity is clinically recognizable when the workup is done. The failure is almost always procedural — the workup was not done, or it was done partially and then abandoned when a more convenient diagnosis was available.

In the typical pattern case, the patient presents with right-upper-quadrant pain. The initial history-taker notes the pain, asks whether it is worse with eating, and records a brief chief complaint of "abdominal pain" or "GERD" or "possible gastroenteritis." The vital signs at triage are acceptable — temperature might be slightly elevated, pulse might be mildly fast — and the patient is placed in a lower-acuity track. The physician or advanced-practice provider arrives, reviews the triage note, and asks a focused set of questions built around the working diagnosis already suggested by the chart. Murphy sign is not formally tested, or it is tested briefly and not documented. No ultrasound is ordered. A CBC may be ordered but the result is interpreted as "mild leukocytosis, non-specific." A trial of antacids and an antiemetic is given. The patient feels somewhat better, because the medication treated the symptom and the underlying process has not progressed to the point where antacids no longer help. The patient is discharged with a follow-up recommendation.

The pattern has a name in cognitive psychology — anchoring bias, with an assist from premature closure. It is not that the physician is careless. It is that the clinical reasoning settled on the first plausible diagnosis before the workup was broad enough to rule out the competing differential. In a right-upper-quadrant pain presentation, acute cholecystitis is the single most dangerous miss on the differential, and the Tokyo Guidelines exist to make sure the clinician considers it systematically rather than intuitively. The full ER failure mode — anchoring, premature closure, the chief-complaint trap — is walked through on ER misdiagnosis of gallbladder pain.

The Tokyo Guidelines TG18 are the reference standard that expert reviewers and hospital quality committees apply when auditing a cholecystitis evaluation. They break the diagnosis into three categories — local signs of inflammation, systemic signs of inflammation, and imaging findings — and define a suspected versus definite diagnosis based on how many categories are positive.

Local signs of inflammation include Murphy sign on physical examination and right-upper-quadrant pain, mass, or tenderness. Systemic signs of inflammation include fever, elevated C-reactive protein, and elevated white blood cell count. Imaging findings characteristic of acute cholecystitis include gallbladder wall thickening, pericholecystic fluid, gallbladder distension, gallstones or sludge, and positive sonographic Murphy sign.

Under TG18, a suspected diagnosis requires at least one local and one systemic sign. A definite diagnosis requires one local sign, one systemic sign, and a confirmatory imaging finding. Severity grading — Grade I (mild), Grade II (moderate), Grade III (severe) — rests on the presence of organ dysfunction and the local inflammatory picture on imaging and at operation. Gangrenous, perforated, abscessed, or peritonitis-producing cholecystitis is Grade III by definition.

When a chart shows right-upper-quadrant pain, a fever, and an elevated white count — and no imaging was ordered — the TG18 framework makes the deviation visible. Under the guideline, suspected acute cholecystitis was present on the record, and the appropriate next step was imaging. The absence of an ultrasound in that scenario is not a judgment call about which test to order. It is the omission of the confirmatory step that the international reference standard specifically calls for. For the full first-line-to-confirmatory cascade — ultrasound, then HIDA when ultrasound is equivocal — see the ultrasound and HIDA scan for cholecystitis guide.

When the workup finally does happen — often at the second visit, sometimes days late — the imaging itself often tells the reviewer how far along the progression had already gone. Radiologists recognize the signature of gangrenous cholecystitis on ultrasound and computed tomography even when the clinician has not anticipated it.

On ultrasound, the classic findings include gallbladder wall thickening greater than three millimeters, pericholecystic fluid, gallstones, and sonographic Murphy sign. When the case has progressed to gangrene, additional findings appear — a striated, disrupted, or irregular wall; intraluminal membranes or sloughed mucosa; pericholecystic abscess; and loss of the normal wall layering. Sonographic Murphy sign may actually become less prominent as the wall necrotizes, because the nerve endings that produce the tenderness are themselves injured — a false-reassurance phenomenon that the American College of Radiology discusses explicitly in its Appropriateness Criteria on right-upper-quadrant pain.

On computed tomography, the gangrenous gallbladder often shows marked wall thickening, extensive pericholecystic fat stranding, fluid collections, and abnormal wall enhancement — the enhancement pattern becomes patchy or absent in the necrotic segments. Gas within the wall or lumen, when present, suggests emphysematous cholecystitis, a related emergency that runs a particularly aggressive course in diabetics.

When a radiology report describes any of these advanced findings, the forensic inference is typically straightforward — the patient did not develop gangrene in the two hours between ER check-in and the scan. The progression had been underway for a day or more. The question then becomes what was and was not done the first time the patient presented.

Several patient populations are statistically overrepresented in the gangrenous-cholecystitis literature, and the risk factors are well-described. Older adults — particularly those over sixty-five — progress more quickly and with fewer textbook symptoms. Their pain may be less localized, their fever may be blunted, and their white blood cell count may be only mildly elevated even at the gangrenous stage. Diabetics are a second high-risk population: they mount a weaker inflammatory response, their autonomic neuropathy can blunt the pain, and they are the group in which emphysematous cholecystitis — a rapidly lethal variant with gas-forming organisms in the wall — concentrates. Immunocompromised patients, including transplant recipients, patients on chronic steroids, and patients with advanced chemotherapy, progress atypically and often late.

Male sex is also associated with a higher rate of gangrenous progression in the published cohorts, as are elevated admission white blood cell counts, higher C-reactive protein values, and delays from symptom onset to presentation. None of these factors individually predict a specific outcome in an individual case, but they are the dials that a competent clinician considers when deciding whether to admit and observe rather than discharge.

The malpractice analysis often hinges on whether these risk factors were documented in the chart. A seventy-year-old diabetic with right-upper-quadrant pain and an elevated white count is not a candidate for a GERD workup and a PPI prescription. The record of what was known about the patient, compared against what was done, is where the case is won or lost.

Across the medical-malpractice literature on emergency-department diagnostic error, the bounce-back case is the most consistent finding. A patient is discharged with a non-emergent working diagnosis, returns within two to three days significantly sicker, and is found on the second workup to have a progression of a condition that was already present at the first visit. In cholecystitis, this pattern is so regular it functions as a clinical-legal signature.

The second-visit chart usually reveals what the first-visit chart should have revealed. White blood cell count is now substantially elevated. Bilirubin, alkaline phosphatase, and liver enzymes are up. The ultrasound that was not performed the first time is now performed, and it shows wall thickening, pericholecystic fluid, and often free intraperitoneal fluid suggesting perforation. The patient is taken to the operating room, and the surgical finding is a gangrenous or perforated gallbladder with bile peritonitis. The operative note, the surgical pathology report, and the post-operative course then become the backbone of the damages analysis.

We build the case around the contrast between the two visits. The first-visit chart — with its incomplete history, its absent imaging, and its confident diagnosis of a benign gastrointestinal condition — stands in sharp relief against the second-visit findings that established the actual diagnosis. In most cases, that contrast is the decisive exhibit.

Case value in a gangrenous-cholecystitis malpractice claim tracks closely with how far the patient progressed before the correct diagnosis was finally made. An uncomplicated laparoscopic cholecystectomy performed three days late, on a patient who recovers within a week, carries modest damages — the delay existed, but the outcome was not fundamentally altered. These cases can still settle, but the numbers are restrained.

A patient who reaches gangrenous cholecystitis without perforation usually requires a more extensive operation, often converted from laparoscopic to open, with a longer hospital stay, a slower recovery, and a higher incidence of post-operative complications including wound infection and prolonged ileus. Damages in these cases include the additional hospital costs, the extended time out of work, and the non-economic damages associated with a more difficult and painful recovery.

A patient who perforates, develops bile peritonitis, and requires ICU-level care for sepsis faces a categorically different damages picture. Economic damages include the intensive-care admission, the extended hospitalization, possible multi-organ support, reoperation if the initial surgery was inadequate, rehabilitation, home health care, and — in cases with permanent physical impairment — reduced future earning capacity. Non-economic damages capture the pain and suffering of critical illness, the psychological aftermath of a near-death experience, and the lasting impact on family and social functioning. In fatal cases, wrongful-death damages under the applicable state statute include final medical expenses, lost future earnings, and compensation for survivors' grief and loss of consortium. The settlement and verdict ranges vary by jurisdiction and by the specific facts, but these are the categories that determine the ceiling.

For a broader discussion of how gallbladder-malpractice case value is calculated across the full range of injuries, see our explainer on how gallbladder malpractice settlements are calculated. For the underlying mini-hub that frames the delayed-diagnosis pattern in full, see delayed diagnosis of cholecystitis.